Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 4, Issue 144, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.3003875
Keywords
-
Categories
Funding
- Ruth L. Kirschstein National Research Service Award Individual Fellowship from the NIH [F32-HL094037]
- Mentored Clinical Scientist Development Award from the NIH [1K08HL105801]
- NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR048997]
- Muscular Dystrophy Association [MDA172222]
Ask authors/readers for more resources
Mutations in the lamin A/C gene (LMNA), which encodes A-type lamins, cause a diverse range of diseases collectively called laminopathies, the most common of which is dilated cardiomyopathy. Emerging evidence suggests that LMNA mutations cause disease by altering cell signaling pathways, but the specific mechanisms are poorly understood. We show that the AKT-mammalian target of rapamycin pathway is hyperactivated in hearts of mice with cardiomyopathy caused by Lmna mutation and that in vivo administration of the rapamycin analog temsirolimus prevents deterioration of cardiac function. We also show defective autophagy in hearts of these mice and demonstrate that improvement in heart function induced by pharmacological interventions is correlated with enhanced autophagy. These findings provide a rationale for treatment of LMNA cardiomyopathy with rapalogs and implicate defective autophagy as a pathogenic mechanism of cardiomyopathy arising from LMNA mutation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available